Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 121.11M P/E - EPS this Y - Ern Qtrly Grth -
Income -11.69M Forward P/E - EPS next Y -6.70% 50D Avg Chg -11.00%
Sales 365k PEG - EPS past 5Y - 200D Avg Chg -17.00%
Dividend N/A Price/Book 50.49 EPS next 5Y - 52W High Chg -92.00%
Recommedations - Quick Ratio 2.95 Shares Outstanding 31.70M 52W Low Chg 12.00%
Insider Own 37.04% ROA -60.92% Shares Float 22.32M Beta -
Inst Own 1.66% ROE -121.56% Shares Shorted/Prior 688.94K/342.89K Price 4.14
Gross Margin 100.00% Profit Margin - Avg. Volume 320,301 Target Price 6.00
Oper. Margin -4,076.02% Earnings Date - Volume 39,250 Change -3.50%
About Monogram Orthopaedics Inc.

Monogram Technologies Inc. focuses on developing a product solution architecture to enable patient-optimized orthopaedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Orthopaedics, Inc. and changed its name to Monogram Technologies Inc. in May 2024. Monogram Technologies Inc. was founded in 2015 and is headquartered in Austin, Texas.

Monogram Orthopaedics Inc. News
11/17/24 Will Monogram Technologies (NASDAQ:MGRM) Spend Its Cash Wisely?
11/14/24 Monogram Technologies Reports Third Quarter 2024 Financial Results
11/12/24 Monogram Technologies to Host Third Quarter 2024 Results Conference Call on Tuesday, November 19, 2024 at 4:30 p.m. Eastern Time
10/31/24 MGRM: Monogram Announces it has Received an Additional Information Request (AIR) from the FDA Regarding its Recent 510(k) Submission.
10/29/24 Monogram Technologies Named Orthopedic Joint Replacement Company of the Year 2024
10/16/24 Monogram Technologies to Present at the LD Micro Main Event XVII Conference on Wednesday October 30, 2024
10/03/24 CORRECTION FROM SOURCE: Monogram Technologies Issues Correction to Press Release Announcing it Received an FDA Response for its mBôs TKA System
10/02/24 Monogram Technologies Receives FDA Response for mBôs TKA System
10/02/24 Monogram Technologies Announces Closing of Upsized and Oversubscribed $13 Million Public Offering
10/01/24 Monogram Technologies Announces Preferred Stock Dividends
09/11/24 Monogram Technologies Upsizes 8.00% Series D Convertible Cumulative Preferred Stock and Warrant Offering to $12.5 Million
08/22/24 MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00
08/14/24 Monogram Technologies Reports Second Quarter 2024 Financial Results
08/12/24 Monogram Technologies Secures Initial Strategic Clinical Trial Collaboration
08/08/24 Monogram Technologies Submits 510(k) Application for mBôs TKA System Clearance
08/01/24 Monogram Technologies to Host Second Quarter 2024 Business Update Conference Call on Wednesday, August 14, 2024 at 4:30 p.m. Eastern Time
07/09/24 Monogram Technologies Launches Continuous Offering of 8.00% Convertible Preferred Stock and Warrants
06/03/24 Monogram Technologies to Host Investor and Analyst Tour at its Headquarters in Austin, Texas, on Thursday, June 20th, 2024
05/15/24 Monogram Orthopaedics Completes Corporate Name Change to Monogram Technologies
05/14/24 Monogram Orthopaedics Reports First Quarter 2024 Financial Results
MGRM Chatroom

User Image Biscuitpants Posted - 3 hours ago

$MGRM Comment n last post: The hidden message in NOTHING'S GUARANTEED??? I think that the CEO believes that he EXPECTS the FDA to take a favorable position on MGRM's proposed testing plan.....see meaning of NOTHING'S GUARANTEED below: Nothing is guaranteed" essentially means that you can't be certain about any outcome in life, and that UNEXPECTED events can happen at any time, so you shouldn't take anything for granted.

User Image Biscuitpants Posted - 3 hours ago

$MGRM CEO from Q3 CC ... "We expect during that meeting (the upcoming planned December FDA meeting) we will get a lot more clarity on whether our proposed testing plan will fully address all the FDA questions and that we're thinking this will be a really critical moment for the company in terms of derisking the application. Obviously NOTHING'S GUARANTEED, but it will certainly be helpful to have a conversation with the FDA for more clarity."

User Image Mptxop Posted - 3 hours ago

$MGRM

User Image Biscuitpants Posted - 1 day ago

$MGRM Comment regarding previous post: MGRM provided written responses regarding the FDA's Additional Information Request (AIR). MGRM thought through how they wanted to address the appropriate testing in cases where they thought appropriate testing would be needed. The MGRM proposed testing does not include OUS clinical trial data. It is believed Monogram is hopeful/expects that an OUS clinical trial will not be needed as part of the NDA application but does NOT want to assume the FDA will agree to such a proposal. If the FDA would like OUS clinical trial data, then (as CEO) stated, we have a plan to get that data very quickly.

User Image Biscuitpants Posted - 1 day ago

$MGRM Takeaway from the CC....CEO stated..... MGRM received comments related to the AIR that stated the FDA did not specifically recommend testing, but made comments that could be inferred to be recommending additional testing. "We have a belt and suspenders plan to getting clearance (OUS clinical trial). If events go great in the December Sub-Q meeting with the FDA and they feel that clinical data is not needed with the application, that's terrific. If the FDA wants clinical data, that's okay as we have a plan to get that data very quickly."

User Image Buttass Posted - 1 day ago

User Image Growth101 Posted - 1 day ago

$MGRM anybody listen to the CC?

User Image Biscuitpants Posted - 3 days ago

$MGRM There is a MGRM CC tomorrow after market close ...hopefully MGRM will clarify milestones/timelines related to the planned clinical trial of 92 patients in India....it would appear from the excerpt below that before a trial can begin in Inda that PROOF OF APPROVAL is needed in the manufacturers home market. According to India's CDSCO regulations, a surgical robot would likely be classified as a Class D medical device, requiring the highest level of scrutiny and would necessitate proof of approval in the manufacturer's home market to facilitate registration in India

User Image Buttass Posted - 3 days ago

$MGRM Getting in early on a cyberpunk company. 20 minute knee surgery would be absolutely insane.

User Image Biscuitpants Posted - 3 days ago

$MGRM https://www.google.com/search?q=cdsco+meical+device+classification+of+a+surgical+robot+in+India+must+show+approval+in+home+market&client=ms-android-samsung-gs-rev1&sca_esv=eabdc2486f328348&sxsrf=ADLYWILtX8Ox8lwAgtwJBzKo3PoBB3mgpg%3A1731944311274&ei=d187Z-69EJPaptQPspmDoQo&oq=cdsco+meical+device+classification+of+a+surgical+robot+in+India+must+show+approval+in+home+market&gs_lp=EhNtb2JpbGUtZ3dzLXdpei1zZXJwImFjZHNjbyBtZWljYWwgZGV2aWNlIGNsYXNzaWZpY2F0aW9uIG9mIGEgc3VyZ2ljYWwgcm9ib3QgaW4gSW5kaWEgbXVzdCBzaG93IGFwcHJvdmFsIGluIGhvbWUgbWFya2V0MgQQHhgKSMX7AVCPQViA8wFwCXgAkAEAmAG3AaABvyOqAQUxNC4yObgBA8gBAPgBAZgCM6ACzyPCAgoQABiwAxjWBBhHwgIEECEYCpgDAOIDBRIBMSBAiAYBkAYIkgcFMjIuMjmgB92fAQ&sclient=mobile-gws-wiz-serp

User Image rossm9 Posted - 5 days ago

$MGRM I don’t post anything, ever… I can tell you this. I firmly believe this is a great product that will enhance the lives of everyone it touches. It is going to be a several year hold though. I will continue picking up shares as we go. Good luck to all those doing the same!

User Image Mptxop Posted - 6 days ago

$MGRM Them not disclosing what the FDA wants is concerning? US trails could cost lots and time.

User Image Mptxop Posted - 1 week ago

$MGRM I transferred some funds to buy under 2$ I hope it clears tomorrow since it’s under 3$!

User Image Growth101 Posted - 1 week ago

$MGRM I don’t think management cares at all about stock price or investors

User Image GoldPannin Posted - 1 week ago

$MGRM SUPER DUPER bullish!

User Image coreholder Posted - 1 week ago

$MGRM Q3 earnings announcement should be this week!

User Image Mptxop Posted - 1 week ago

$MGRM Getting closer to my buy more price of under 2$!

User Image skipperdr Posted - 1 week ago

$MGRM I’m adding to my position as longs as it’s under $2.30.

User Image Boxcar66 Posted - 1 week ago

$MGRM nice

User Image coreholder Posted - 2 weeks ago

$MGRM lol 😆 trading all over the place today

User Image coreholder Posted - 2 weeks ago

$MGRM Nice after hours action

User Image Buttass Posted - 2 weeks ago

$MGRM Took a position at $2.28

User Image coreholder Posted - 2 weeks ago

$MGRM Bullish on this company’s future

User Image snapbuy Posted - 10/25/24

$MGRM will this ever burst?

User Image Gino2186 Posted - 1 month ago

$MGRM these dividends arent looking to bad. im glad i held.

User Image coreholder Posted - 1 month ago

$MGRM nice breaking out of support range

User Image Princeb Posted - 1 month ago

$MGRM anyone get an email that preferred shares were converted to common? I got an email 10/15 that it was converted without my authorization

User Image Baabboon69 Posted - 1 month ago

$MGRM

User Image LowT Posted - 1 month ago

$MGRM $120K purchase this morning. Something is definitely brewing this week 💎🤚

User Image RemitTekram Posted - 1 month ago

$STXS This is looking pretty strong here. Have to be in robotics surgery. Going to happen! $MGRM may be a good one too. Their collaboration with nvidia will only help their design.